Question Everything. See who's reporting it.

Novo scraps two heart drug trials, continues ziltivekimab trial for 2027

Source: Deccan Herald

The story in brief

Novo Nordisk has scrapped two heart drug trials, further limiting growth beyond obesity. However, a trial testing ziltivekimab in heart attack recovery patients will continue, with results expected in early 2027. Data collected includes IP addresses, device identifiers, and location data.

NEWXFree on Android and iPhone. Open in NEWX